首页> 外文OA文献 >Faculty Opinions recommendation of The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

【2h】

Faculty Opinions recommendation of The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

机译：教师意见建议加入Cixutumumab或替替莫唑代族化学疗法的增加是可行的，但不会改善转移性横纹肌肉瘤患者的结果：儿童肿瘤组的报告。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Alberto Pappo;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma A report from the Children's Oncology Group [J] . Malempati Suman, Weigel Brenda J., Chi Yueh-Yun, Cancer: A Journal of the American Cancer Society . 2019,第2期

机译：加入Cixutumumab或替替莫唑胺至密集的多元化疗是可行的，但不会改善横纹肌肉瘤患者的结果，来自儿童肿瘤学组的报告
2. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. [J] . Chou AJ, Kleinerman ES, Krailo MD Cancer: A Journal of the American Cancer Society . 2009,第22期

机译：对于新诊断的转移性骨肉瘤患者，在化疗中添加穆拉米三肽：儿童肿瘤学组的报告。
3. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. [J] . Bernstein ML, Devidas M, Lafreniere D, Journal of Clinical Oncology . 2006,第1期

机译：生长因子支持的强化疗法对确诊为尤文肿瘤转移的患者的诊断：小儿肿瘤学组/儿童癌症组II期研究9457 –儿童肿瘤学组的报告。
4. Intensive Multiagent Therapy Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide Irinotecan and Radiation in Patients With High-Risk Rhabdomyosarcoma: A Report From the Childrens Oncology Group [O] . Brenda J. Weigel, Elizabeth Lyden, James R. Anderson, -1

机译：高危性横纹肌肉瘤患者的强化多药物治疗包括异环磷酰胺/依托泊苷和长春新碱/阿霉素/环磷酰胺伊立替康和放射的剂量压缩周期：儿童肿瘤学组的报告
5. Faculty Opinions recommendation of Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. [O] . Alberto Pappo 2020

机译：教师意见建议加入血管链和伊替康至中文克里汀，丁霉素和环磷酰胺并未改善中间风险rhabdomyosarcoma的结果：儿童肿瘤组的报告。

Faculty Opinions recommendation of The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

著录项

相似文献

相关主题

期刊订阅